Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2004;329 (2 October), doi:10.1136/bmj.329.7469.0-d
Extensive misuse of drugs during Ramadan may lead to therapeutic failure. On p 778 Aadil and colleagues analyse how the change of dosing time and schedule may affect the efficacy of treatment. Slow release formulations and a lower number of daily doses may improve the plasma concentration of some drugs, but the potential for toxicity is high for drugs with a narrow therapeutic range. During Ramadan patients arbitrarily modify their dosing schedules and even total daily dosage, often without medical advice. Patients often insist on fasting, even though those with chronic diseases are permitted not to fast and patients with acute diseases are allowed to stop fasting and make up for it after Ramadan.
|
|
Credit: K NOMACHI/REX
|
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
What can you learn from this BMJ paper? Read Leanne Tite's Paper+